IJMSX | VMVAX | IJMSX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 13 years | - |
Gain YTD | 11.908 | 17.355 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 307M | 30.9B | 1% |
Annual Yield % from dividends | 0.85 | 2.14 | 40% |
Returns for 1 year | 21.87 | 27.09 | 81% |
Returns for 3 years | -14.90 | 13.54 | -110% |
Returns for 5 years | 0.82 | 47.45 | 2% |
Returns for 10 years | -18.84 | 96.84 | -19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EPVIX | 10.61 | -0.01 | -0.09% |
EuroPac International Value I | |||
EAMAX | 15.79 | -0.05 | -0.32% |
Lord Abbett Emerging Markets Equity A | |||
GSVUX | 19.17 | -0.07 | -0.36% |
Goldman Sachs Large Cap Value R6 | |||
APHIX | 30.03 | -0.37 | -1.22% |
Artisan International Institutional | |||
GSCGX | 36.02 | -0.52 | -1.42% |
Goldman Sachs Large Cap Core A |